SP on Dementia and Cognitive Disorders Panel met during recent EAN Congress in Amsterdam. Co-chairs Reinhold Schmidt from Austria and Jakub Hort from Czech Republic welcomed members and announced that Prof. Dafin Muresanu from Romania has been appointed as… Continue Reading

  The Panel met at the EAN Congress in Amsterdam and the Co-Chairs presented the main points from the Panel Chairs meeting.  It was agreed that the Panel would approach all members to suggest a Neurologist in training to join… Continue Reading

In 2018, the EAN will offer 35 Clinical Fellowships.

Report from Dr Meri Grigoryan, from Yerevan, Armenia visiting the Department of Neurology, Universitatsklinikum Heidelberg, Germany under the supervision of prof. Peter Ringleb

The new CME article October 2017: “European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis – endorsed by the European Academy of Neurology” is online now! Please log-in and browse to the LEARN section on the… Continue Reading

Dear Readers, An interesting interactive case has been published in eBrain this month. It has been written by the Neurology, Neuroscience and Stroke Unit teams from UCL Belgium. Please, find below the abstract. To see the full case, please log-in via the EAN-website, and once you are on the eBrain page, go to “virtual patient cases”:

During the general assembly of the Resident and Research Fellow Section (RRFS) on June 26, 2017 it was concluded that an update of the RRFS membership criteria was needed. Many neurologists in training across Europe conduct a postgraduate degree such as Master or MD or PhD program after their residency and these people should still be eligible as RRFS members until 3 years since their latest degree as we believe the RRFS section is relevant for them during this period.

A new guideline on cerebral venous thrombosis (CVT) diagnosis and treatment issued by the European Stroke Organization (ESO) and endorsed by the European Academy of Neurology (EAN) was recently published in ESO (long version) and EAN (abbreviated version) official journals [1, 2].

It is a pleasure to share with the European neurological community the outcome of the first teaching course for rare neurological diseases. The course took place in Cluj-Napoca, Romania, from 7th to 9th September 2017.

Please find below articles from Belgian authors and co-authors that were published in the European Journal of Neurology

EARLS is a non–profit independent alliance of national Restless Legs Syndrome (RLS - also known as Willis Ekbom Disease) European patient organizations. Launched in November 2009, EARLS had six founding members: Belgium, Finland, Spain, Sweden, The Netherlands and the United Kingdom. France, Norway and Austria have now also joined.

Belgium occupies a central position in Western Europe, bordered by France, the Netherlands, Germany, Luxembourg, and the North Sea. Densely populated since ancient times, its inhabitants were famously dubbed by Caesar as “the strongest of the Gauls” (Horum omnium fortissimi sunt Belgae). In the Middle Ages this geographical area was occupied by independent fiefdoms which were later united with the northern Dutch provinces by the Dukes of Burgundy; together, they were called “The Low Countries”

Prof. Gunhild Waldemar (GW): Geriatric medicine has become very important in our fast ageing European population.I invite you to introduce the European Union Geriatric Medicine Society – EUGMS of which you are the president to the EANpages readership. Can you please explain to the readers of the EAN Pages what the EUGMS stands for and what its objectives and aims are? Prof. Stefania Maggi (SM): The European Union Geriatric Medicine Society, EUGMS, is the collaborating and co-ordinating organisation of the national geriatric medical societies of the European Union member states, but also includes Norway, Switzerland and Iceland. The EUGMS’ mission is to develop geriatric medicine in all member states as a recognised independent medical specialty, contributing to the care of all older people with age related diseases.

For October 2017, we have selected: Andersen G, Hedermann G, Witting N, Duno M, Andersen H, Vissing J. The antimyotonic effect of lamotrigine in non-dystrophic myotonias: a double-blind randomized study. Brain 2017;140:2295-2305. Patients with myotonia congenita and paramyotonia congenita can be disabled by the myotonic phenomenon in the activities of daily living, with a huge impact on their quality of life.